Internet-delivered Cognitive Behaviour Therapy for Older Adults With Anxiety

March 1, 2016 updated by: Gerhard Andersson, Linkoeping University

Individually-tailored Internet-delivered Cognitive Behaviour Therapy Treatment for Older Adults With Anxiety and Depression: a Randomized Controlled Trial

The purpose of this study is to determine whether tailored internet-administrated cognitive behaviour therapy (ICBT) is a feasible approach in the treatment of anxiety symptoms and comorbid depressive symptoms in older adults.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

66

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Have anxiety symptoms

Exclusion Criteria:

  • Suicidal ideation
  • Alcohol addiction
  • Other major primary psychiatric disorder
  • Ongoing psychological treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Tailored Internet-delivered CBT
Tailored Internet-delivered CBT during 8 weeks.
Behavioral: Tailored Internet-delivered CBT
Tailored Internet-delivered CBT during 8 weeks.
Active Comparator: Waitlist
Weekly check-up.
Behavioral: Waitlist
Weekly check up.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Beck Anxiety Inventory (BAI)
Time Frame: Two weeks pre treatment, two weeks post treatment and 12 months post treatment
Change from baseline in symptoms two weeks post treatment and at 12 months post treatment.
Two weeks pre treatment, two weeks post treatment and 12 months post treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Health Questionnaire (PHQ)
Time Frame: Two weeks pre treatment, two weeks post treatment and 12 months post treatment
Change from baseline in symptoms two weeks post treatment and at 12 months post treatment.
Two weeks pre treatment, two weeks post treatment and 12 months post treatment
The Generalized Anxiety Disorder 7-item Scale (GAD-7)
Time Frame: Two weeks pre treatment, two weeks post treatment and 12 months post treatment
Change from baseline in symptoms two weeks post treatment and at 12 months post treatment.
Two weeks pre treatment, two weeks post treatment and 12 months post treatment
Quality of Life Inventory (QOLI)
Time Frame: Two weeks pre treatment, two weeks post treatment and 12 months post treatment
Change from baseline in symptoms two weeks post treatment and at 12 months post treatment.
Two weeks pre treatment, two weeks post treatment and 12 months post treatment
Montgomery Åsberg Depression Rating Scale - Self Rated (MADRS-S)
Time Frame: Two weeks pre treatment, two weeks post treatment and 12 months post treatment
Change from baseline in symptoms two weeks post treatment and at 12 months post treatment.
Two weeks pre treatment, two weeks post treatment and 12 months post treatment
Clinical Outcome in Routine Evaluation - Outcome Measure (CORE-OM)
Time Frame: Two weeks pre treatment, two weeks post treatment and 12 months post treatment
Change from baseline in symptoms two weeks post treatment and at 12 months post treatment.
Two weeks pre treatment, two weeks post treatment and 12 months post treatment
Cognitive Failures Questionnaire (CFQ)
Time Frame: Two weeks pre treatment, two weeks post treatment and 12 months post treatment
Two weeks pre treatment, two weeks post treatment and 12 months post treatment
Wisconsin Card Sorting Test-64 (WCST-64)
Time Frame: Two weeks pre treatment, two weeks post treatment and 12 months post treatment
Two weeks pre treatment, two weeks post treatment and 12 months post treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Linkoeping University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2012

Primary Completion (Actual)

December 1, 2015

Study Completion (Actual)

December 1, 2015

Study Registration Dates

First Submitted

March 26, 2015

First Submitted That Met QC Criteria

March 26, 2015

First Posted (Estimate)

March 31, 2015

Study Record Updates

Last Update Posted (Estimate)

March 2, 2016

Last Update Submitted That Met QC Criteria

March 1, 2016

Last Verified

March 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • GA-Forte-Older-Adults-Anx

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on Tailored Internet-delivered CBT

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe